Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Newron Pharmaceuticals S.p.A. Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.	Italy	NWRN
NEXGEL, INC. Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.	United States of America	NXGL
NextCell Pharma AB Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.	Sweden	NXTCL
NextCure, Inc. Clinical-stage biopharma developing novel immunomedicines for cancer and other diseases.	United States of America	NXTC
NGeneBio Co., Ltd. Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.	South Korea	354200
NIBEC CO., LTD. Biotech CDMO creating regenerative products with peptide and biomaterial technologies.	South Korea	138610
NIPPON CHEMIPHAR CO., LTD. Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.	Japan	4539
Nippon Shinyaku Co.,Ltd. Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.	Japan	4516
Nkarta, Inc. Developing off-the-shelf NK cell therapies for cancer and autoimmune diseases.	United States of America	NKTX
NKMAX Co., Ltd. Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.	South Korea	182400